China Sky One Medical, Inc.a pharmaceutical company producing external use, over-the-counter drugs in the PRC announced that it has successfully developed a propyl gallate injection for the treatment of acute cerebral infarction, coronary heart disease, thrombosis, dysmenorrhea and nephropathy. Heilongjiang Tianlong Pharmaceutical, Inc., a wholly-owned subsidiary of China Sky One Medical, Inc., recently completed research and [...]

Original URL: Click here to visit original article
Copyright China Sourcing News